Portal de Periódicos da CAPES

A Normal Fixed‐Loss Component of Platelet Utilization Accounting for Short Survival of Transfused Plateletsa

1985; Wiley; Volume: 459; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1985.tb20846.x

1749-6632

N. Raphael Shulman, James V. Jordan, Steven C. Falchuk,

Platelet Disorders and Treatments

Annals of the New York Academy of SciencesVolume 459, Issue 1 p. 367-374 A Normal Fixed-Loss Component of Platelet Utilization Accounting for Short Survival of Transfused Plateletsa N. RAPHAEL SHULMAN, N. RAPHAEL SHULMAN Clinical Hematology Branch National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorJAMES V. JORDAN JR., JAMES V. JORDAN JR. Clinical Hematology Branch National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorSTEVEN FALCHUK, STEVEN FALCHUK Clinical Hematology Branch National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20205Search for more papers by this author N. RAPHAEL SHULMAN, N. RAPHAEL SHULMAN Clinical Hematology Branch National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorJAMES V. JORDAN JR., JAMES V. JORDAN JR. Clinical Hematology Branch National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20205Search for more papers by this authorSTEVEN FALCHUK, STEVEN FALCHUK Clinical Hematology Branch National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland 20205Search for more papers by this author First published: December 1985 https://doi.org/10.1111/j.1749-6632.1985.tb20846.xCitations: 2 a This work was presented in part in References 1 and 2. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Shulman, N. R. & J. V. Jordan 1981. A fixed-loss component of platelet utilization accounting for short survival of transfused platelets. Clin. Res. 29(2): 572a. (Abstract.). 2 Shulman, N. R. & J. V. Jordan 1982. Platelet dynamics. In Hemostasis and Thrombosis. R. Colman & J. Hirsh & V. Marder & E. Salzman, Eds.: 237–258. Lippincott. Philadelphia , Pa . 3 Aster, R. H. & J. H. Jandl 1964. Platelet sequestration in man I. Methods. J. Clin. Invest. 43: 843. 4 Aas, K. A. & F. H. Gardner 1958. Survival of blood platelets labeled with chromium51. J. Clin. Invest. 37: 1257. 5 Abrahamsen, A. F. 1965. The effect of EDTA and ACD on the recovery and survival of Cr51-labelled blood platelets. Scand. J. Haematol. 2: 52. 6 Shulman, N. R., V. J. Marder & R. S. Weinrach 1965. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic, and isotope studies. Ann. N.Y. Acad. Sci. 124: 499. 7 Kotilainen, M. 1969. Platelet kinetics in normal subjects and in haematological disorders. Scand. J. Haematol. Suppl. 5: 32. 8 O'Neill, B. & B. Firkin 1964. Platelet survival studies in coagulation disorders, thrombocythemia, and conditions associated with atherosclerosis. J. Lab. Clin. Med. 64: 188. 9 Murphy, E. A. & J. F. Mustard 1971. Studies of platelet economy. In Platelet Kinetics. J. M. Paulus, Ed.: 24. North-Holland. Amsterdam , The Netherlands . 10 Ginsburg, A. D. & R. H. Aster 1969. Kinetic studies with 51chromium-labeled platelet cohorts in rats. J. Lab. Clin. Med. 74: 138. 11 International Committee for Standardization in Hematology. 1977. Recommended methods for radioisotope platelet survival studies. Blood 50: 1137. 12 Dornhorst, A. C. 1951. The interpretation of red cell survival curves. Blood 6: 1284. 13 Heyssel, R. M., L. J. Silver, M. Wasson & A. B. Brill 1967. The relation of blood platelet survival and distribution to 14C-serotonin distribution and excretion. Blood 29: 341. 14 Cronkite, E. P., V. P. Bond, T. M. Fliedner, D. A. Paglia & E. R. Adamik 1961. Studies on the origin, production and destruction of platelets. In The Blood Platelet. S. A. Johnson & R. W. Monto & J. W. Rebuck & R. C. Horn, Eds.: 595. Little, Brown. Boston , Mass. 15 Wojcik, J. D., D. L. Van Horn, A. J. Webber & S. A. Johnson 1969. Mechanism whereby platelets support the endothelium. Transfusion 9(6): 324. 16 Hirsch, E. O. & F. H. Gardner 1952. The transfusion of human blood platelets. With a note on the transfusion of granulocytes. J. Lab. Clin. Med. 39: 556. 17 Aster, R. H. 1967. Studies of the mechanism of “hypersplenic” thrombocytopenia in rats. J. Lab. Clin. Med. 70: 736. 18 Aster, R. H. & J. H. Jandl 1964. Platelet sequestration in man II. Immunological and clinical studies. J. Clin. Invest. 43: 856. 19 Aster, R. H. 1969. Studies of the fate of platelets in rats and man. Blood 34: 117. Citing Literature Volume459, Issue1Hematopoietic Cellular Proliferation: An International Conference in Honor of Eugene P. CronkiteDecember 1985Pages 367-374 ReferencesRelatedInformation